Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
17.1M
-
Shares change
-
-875K
-
Total reported value, excl. options
-
$141M
-
Value change
-
-$14.2M
-
Put/Call ratio
-
0.21
-
Number of buys
-
42
-
Number of sells
-
-39
-
Price
-
$8.30
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2018
99 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2018.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.1M shares
of 60M outstanding shares and own 28.56% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.09M shares), FMR LLC (2.56M shares), 683 Capital Management, LLC (1.39M shares), BlackRock Inc. (1.3M shares), SPHERA FUNDS MANAGEMENT LTD. (1.23M shares), Vanguard Group Inc (1.1M shares), MANGROVE PARTNERS (708K shares), MILLENNIUM MANAGEMENT LLC (658K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (545K shares), and Knoll Capital Management, LP (484K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.